Fund Holdings — Iron Triangle Partners LP

Total Portfolio Value:
$966.39M
Total Bought:
$528.24M
Total Sold:
$340.49M
Net Transaction:
+$187.75M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Acadia Healthcare Company, Inc.(ACHC)791,993902,813+110,820$61.59M$71.52M7.40%+$9.94M
DexCom, Inc.(DXCM)290,000471,631+181,631$35.99M$65.42M6.77%+$29.43M
ICON Public Limited CompanySHS(ICLR)172,675150,853-21,822$48.88M$50.68M5.24%+$1.80M
AbbVie Inc.(ABBV)250,000276,098+26,098$38.74M$50.28M5.20%+$11.53M
Intuitive Surgical, Inc.(ISRG)120,000124,337+4,337$40.48M$49.62M5.13%+$9.14M
Endeavour Silver Corp.(EXK)0700,000+700,000$0$48.34M5.00%+$48.34M
West Pharmaceutical Services, Inc.(WST)0119,736+119,736$0$47.38M4.90%+$47.38M
Align Technology Inc0141,958+141,958$0$46.55M4.82%+$46.55M
Illumina, Inc.(ILMN)220,000330,758+110,758$30.63M$45.42M4.70%+$14.79M
Bruker Corporation(BRKR)450,000466,521+16,521$33.07M$43.82M4.53%+$10.76M
Glaukos Corporation(GKOS)244,606429,525+184,919$19.44M$40.50M4.19%+$21.06M
Teva Pharmaceutical Industries LimitedADS(TEVA)1,300,0002,769,864+1,469,864$13.57M$39.08M4.04%+$25.51M
Brookdale Senior Living Inc.(BKD)4,859,6075,897,960+1,038,353$28.28M$38.99M4.03%+$10.70M
Apellis Pharmaceuticals Inc
COM
0550,000+550,000$0$32.33M3.35%+$32.33M
Fortrea Holdings Inc.(FTRE)0791,233+791,233$0$31.76M3.29%+$31.76M
Neurocrine Biosciences, Inc.(NBIX)0220,000+220,000$0$30.34M3.14%+$30.34M
Avantor, Inc.(AVTR)01,150,000+1,150,000$0$29.41M3.04%+$29.41M
Shockwave Med Inc079,736+79,736$0$25.96M2.69%+$25.96M
Schrödinger, Inc.(SDGR)468,585863,323+394,738$16.78M$23.31M2.41%+$6.53M
Syndax Pharmaceuticals, Inc.(SNDX)0973,057+973,057$0$23.16M2.40%+$23.16M
Spdr Ser TrS P BIOTECH
ST STR SP BIOT
0226,066+226,066$0$21.45M2.22%+$21.45M
Elanco Animal Health Incorporated(ELAN)3,000,0001,297,132-1,702,868$44.70M$21.12M2.19%-$23.58M
Cytokinetics, Incorporated(CYTK)0300,000+300,000$0$21.03M2.18%+$21.03M
McKesson Corporation(MCK)80,00037,419-42,581$37.04M$20.09M2.08%-$16.95M
Oscar Health, Inc.CL A(OSCR)2,052,5511,334,503-718,048$18.78M$19.84M2.05%+$1.06M
argenx SEADR(ARGX)045,000+45,000$0$17.72M1.83%+$17.72M
908 Devices Inc.(MASS)1,284,9471,040,768-244,179$14.42M$7.86M0.81%-$6.56M
Nyxoah S ASHS
SHS
0253,025+253,025$0$3.41M0.35%+$3.41M
10x Genomics, Inc.CL A(TXG)479,3740-479,374$26.83M$0—-$26.83M
BioMarin Pharmaceutical Inc.(BMRN)200,0000-200,000$19.28M$0—-$19.28M
Establishment Labs Holdings Inc.(ESTA)331,2380-331,238$8.58M$0—-$8.58M
IDEXX Laboratories, Inc.(IDXX)76,0250-76,025$42.20M$0—-$42.20M
Inspire Medical Systems, Inc.(INSP)150,0000-150,000$30.51M$0—-$30.51M
Legend Biotech CorporationADS(LEGN)380,0000-380,000$22.86M$0—-$22.86M
Pacific Biosciences of California, Inc.(PACB)1,843,2780-1,843,278$18.08M$0—-$18.08M
Repligen Corporation(RGEN)82,5370-82,537$14.84M$0—-$14.84M
SanofiADR(SNY)500,0000-500,000$24.86M$0—-$24.86M
Surgery Partners, Inc.(SGRY)1,044,5300-1,044,530$33.41M$0—-$33.41M
Universal Health Services, Inc.CL B(UHS)321,8860-321,886$49.07M$0—-$49.07M
Page 1 of 1
Iron Triangle Partners LP — 13F Holdings — Q1 2024 | TickerTrail